{
    "2018-02-08": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Novartis' Cosentyx Label Expanded to Include Scalp Psoriasis",
                "features": {
                    "keywords": [
                        "Cosentyx",
                        "label expansion",
                        "scalp psoriasis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up",
                "features": {
                    "keywords": [
                        "FDA approval",
                        "Gilead",
                        "HIV therapy",
                        "stock up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Venclexta May Prove a Novel Chemotherapy-Free Treatment Option",
                "features": {
                    "keywords": [
                        "Venclexta",
                        "chemotherapy-free",
                        "treatment option"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Imbruvica Leads in the Chronic Lymphocytic Leukemia Space",
                "features": {
                    "keywords": [
                        "Imbruvica",
                        "chronic lymphocytic leukemia",
                        "leadership"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Here's What Gilead Sciences Just Said About Its Future",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "future outlook"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "What Are the Best Healthcare Stocks to Buy? Here Are a Top AI System's 5 Favorites",
                "features": {
                    "keywords": [
                        "healthcare stocks",
                        "AI system",
                        "favorites"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "ABBV to Focus on Advancing Late-Stage Immunology Research in 2018",
                "features": {
                    "keywords": [
                        "ABBV",
                        "immunology research",
                        "late-stage"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}